FBT vs. NBTK.DE
Compare and contrast key facts about First Trust Amex Biotechnology Index (FBT) and Invesco Nasdaq Biotech UCITS ETF (NBTK.DE).
FBT and NBTK.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FBT is a passively managed fund by First Trust that tracks the performance of the NYSE Arca Biotechnology Index. It was launched on Jun 23, 2006. NBTK.DE is a passively managed fund by Invesco that tracks the performance of the Nasdaq Biotechnology. It was launched on Nov 6, 2014. Both FBT and NBTK.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
FBT vs. NBTK.DE - Performance Comparison
Loading graphics...
FBT vs. NBTK.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | -1.95% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 16.73% |
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 2.33% | 33.89% | -1.41% | 5.75% | -11.28% | -1.02% | 25.79% | 17.76% |
Different Trading Currencies
FBT is traded in USD, while NBTK.DE is traded in EUR. To make them comparable, the NBTK.DE values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, FBT achieves a -1.95% return, which is significantly lower than NBTK.DE's 2.33% return.
FBT
- 1D
- 0.84%
- 1M
- -1.41%
- YTD
- -1.95%
- 6M
- 9.21%
- 1Y
- 23.14%
- 3Y*
- 9.56%
- 5Y*
- 4.87%
- 10Y*
- 8.68%
NBTK.DE
- 1D
- 1.96%
- 1M
- -1.29%
- YTD
- 2.33%
- 6M
- 17.31%
- 1Y
- 39.81%
- 3Y*
- 13.31%
- 5Y*
- 4.65%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBT vs. NBTK.DE - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is higher than NBTK.DE's 0.40% expense ratio.
Return for Risk
FBT vs. NBTK.DE — Risk / Return Rank
FBT
NBTK.DE
FBT vs. NBTK.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and Invesco Nasdaq Biotech UCITS ETF (NBTK.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT | NBTK.DE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.95 | 1.74 | -0.79 |
Sortino ratioReturn per unit of downside risk | 1.45 | 2.30 | -0.85 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.31 | -0.12 |
Calmar ratioReturn relative to maximum drawdown | 1.34 | 3.04 | -1.71 |
Martin ratioReturn relative to average drawdown | 4.04 | 14.30 | -10.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBT | NBTK.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.95 | 1.74 | -0.79 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.23 | 0.22 | +0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.50 | 0.44 | +0.06 |
Correlation
The correlation between FBT and NBTK.DE is 0.60, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
FBT vs. NBTK.DE - Dividend Comparison
Neither FBT nor NBTK.DE has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
FBT vs. NBTK.DE - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, which is greater than NBTK.DE's maximum drawdown of -38.18%. Use the drawdown chart below to compare losses from any high point for FBT and NBTK.DE.
Loading graphics...
Drawdown Indicators
| FBT | NBTK.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.51% | -30.99% | -9.52% |
Max Drawdown (1Y)Largest decline over 1 year | -14.26% | -15.66% | +1.40% |
Max Drawdown (5Y)Largest decline over 5 years | -29.05% | -30.99% | +1.94% |
Max Drawdown (10Y)Largest decline over 10 years | -32.37% | — | — |
Current DrawdownCurrent decline from peak | -8.73% | -1.01% | -7.72% |
Average DrawdownAverage peak-to-trough decline | -11.22% | -10.84% | -0.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.71% | 2.89% | +1.82% |
Volatility
FBT vs. NBTK.DE - Volatility Comparison
First Trust Amex Biotechnology Index (FBT) has a higher volatility of 8.73% compared to Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) at 7.53%. This indicates that FBT's price experiences larger fluctuations and is considered to be riskier than NBTK.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBT | NBTK.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.73% | 7.53% | +1.20% |
Volatility (6M)Calculated over the trailing 6-month period | 15.54% | 14.80% | +0.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.78% | 22.80% | +1.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.71% | 21.23% | +0.48% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.06% | 22.73% | +1.33% |